- Sana Biotechnology Announces Publication in Nature Biotechnology of in . . .
Sana Biotechnology, Inc is focused on creating and delivering engineered cells as medicines for patients We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients
- Sanaahousecafe – Yemeni Cafe
Sana’a cafe was born out of a passion for Yemeni coffee and a desire to share its hidden treasures with the world Our story begins in the mystical mountains of Yemen, where coffee has been cultivated for centuries
- Sana (singer) - Wikipedia
Sana Minatozaki (Japanese: 湊﨑 紗夏; [1] born December 29, 1996), known mononymously as Sana (Korean: 사나; Japanese: サナ), is a Japanese singer based in South Korea She is a member of the South Korean girl group Twice, formed in 2015 by JYP Entertainment, and its subunit MiSaMo, formed in 2023
- Workday Completes Acquisition of Sana - Nov 4, 2025
PLEASANTON, Calif , Nov 4, 2025 PRNewswire -- Workday, Inc (NASDAQ: WDAY), the enterprise AI platform for managing people, money, and agents, today announced it has completed its acquisition of Sana, a leading AI company building the next generation of enterprise knowledge tools
- SANA News Today | Why did Sana Biotechnology stock go down . . . - MarketBeat
Read today's SANA news from trusted media outlets at MarketBeat
- Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to . . .
Sana Biotechnology’s share price has had a dramatic ride lately, climbing nearly 7% in just one day and soaring over 160% year-to-date, even against the backdrop of a recent pullback and a 1
- Sana (TWICE) profile, age facts (2025 updated) | kpopping
Sana Minatozaki is a Japanese singer-songwriter and dancer under JYP Entertainment She is best known as a sub-vocalist of the sensational girl group TWICE She is also a member of TWICE's Japanese subunit MISAMO
- SANA Stock Price | Sana Biotechnology Inc. Stock Quote (U. S. : Nasdaq . . .
Sana Biotechnology, Inc engages in the research and development of engineered cells as medicine It focuses on identifying and developing potential product candidates, executing preclinical
|